A new analysis has found that genetic alterations in a particular cellular pathway are linked with bladder cancer risk, recurrence, disease progression, and patient survival. Published early online in CANCER, a peer- reviewed journal of the American Cancer Society, the findings could help improve bladder cancer screening and treatment. Read more here.
Study mentioned: Lee EK, et al. Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer. Cancer. 2013 Mar 25. [Epub ahead of print] PMID: 23529717
No comments:
Post a Comment